Literature DB >> 7867667

Enantiospecific analysis: applications in bioanalysis and metabolism.

A J Hutt1, M R Hadley, S C Tan.   

Abstract

Enantiospecific analysis has a significant role in modern drug development from discovery-chemistry to the clinical evaluation of novel compounds. Chromatographic techniques, involving the use of either chiral derivatizing agents or chiral stationary phases, represent the most commonly used approaches to enantiospecific analysis. The advantages and limitations of these two techniques are examined using the analysis of the enantiomers of the 2-arylpropionic acids (tiaprofenic acid and ibuprofen) and the chiral N-oxides of N-ethyl-N-methylaniline and pargyline, as representative examples for each approach. The potential of biosensors in enantiospecific analysis is addressed and some preliminary results on the development of an enantioselective biosensor for the analysis of (S)-warfarin are presented.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867667     DOI: 10.1007/BF03188927

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  26 in total

Review 1.  Preparative chromatographic separation of enantiomers.

Authors:  E Francotte; A Junker-Buchheit
Journal:  J Chromatogr       Date:  1992-04-15

2.  Rapid and sensitive high-performance liquid chromatographic assay of tiaprofenic acid enantiomers in human plasma and urine.

Authors:  R Mehvar; F Jamali; F M Pasutto
Journal:  J Chromatogr       Date:  1988-03-04

Review 3.  Biosensors for the determination of drug substances.

Authors:  G G Guilbault; R D Schmid
Journal:  Biotechnol Appl Biochem       Date:  1991-10       Impact factor: 2.431

Review 4.  Chiral drugs: an industrial analytical perspective.

Authors:  T J Wozniak; R J Bopp; E C Jensen
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

Review 5.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

6.  Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers.

Authors:  A Avgerinos; A J Hutt
Journal:  Chirality       Date:  1990       Impact factor: 2.437

7.  Enantioselective drug monitoring of (R)- and (S)- propranolol in human plasma via derivatization with optically active (R,R)-O,O-diacetyl tartaric acid anhydride.

Authors:  W Lindner; M Rath; K Stoschitzky; G Uray
Journal:  J Chromatogr       Date:  1989-02-24

8.  Application of a radial compression column to the high-performance liquid chromatographic separation of the enantiomers of some 2-arylpropionic acids as their diastereoisomeric s-(-)-1-(naphthen-1-yl)ethylamines.

Authors:  A J Hutt; S Fournel; J Caldwell
Journal:  J Chromatogr       Date:  1986-06-13

9.  Derivatization of chiral amines with (S,S)-N-trifluoroacetylproline anhydride for GC estimation of enantiomeric composition.

Authors:  J D Adams; T F Woolf; A J Trevor; L R Williams; N Castagnoli
Journal:  J Pharm Sci       Date:  1982-06       Impact factor: 3.534

10.  Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalers.

Authors:  R L Fitzgerald; J M Ramos; S C Bogema; A Poklis
Journal:  J Anal Toxicol       Date:  1988 Sep-Oct       Impact factor: 3.367

View more
  3 in total

Review 1.  Stereoselectivity of antibodies for the bioanalysis of chiral drugs.

Authors:  P A Got; J M Scherrmann
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 3.  Chirality and drugs used in psychiatry: nice to know or need to know?

Authors:  R M Lane; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.